Chevy Chase Clinical Research

Chevy Chase Clinical Research is the largest research center of its kind in the region with approximately 90,000 patients in its database. Established in 1996 as part of Affiliated Research Centers, it is now an independent research site. Under the direction of Medical Director Dr. Louis Korman, more than 300 studies have been conducted in all areas of Gastroenterology and some areas of Internal Medicine.

Chevy Chase Clinical Research

For patients who do not respond to traditional therapy, our clinical research center offers an opportunity to access new alternatives only available through clinical trials. Working closely with a medical staff that includes physician and physician assistant sub-investigators as well as a registered nurse (RN), a certified licensed practical nurse (LPN-C) and certified clinical research (CCRC) coordinators, patients can seek new options and make valuable contributions to the field of medicine.  All trial related tests and procedures are provided at no charge to the patient or their insurance company and, generally, a stipend is provided to cover other incremental expenses, such as, parking and transportation.  The majority of studies are Phase II and Phase III, a designation that indicates the testing of a new drug or therapy to observe and/or measure its effectiveness.  

Medical Director

Robert Hardi, MD, AGAF, CPI

Louis Korman, MD

Dr. Korman completed his medical school education at the State University of New York in Syracuse, graduating Cum Laude and being elected to the Alpha Omega Alpha Medical Honor Society. He moved to Washington, DC in 1978 to continue his training  read more...